Cargando…
Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
BACKGROUND: Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL. METHODS: We analysed 51 prospectively collected pretreatment...
Autores principales: | Taskinen, Minna, Louhimo, Riku, Koivula, Satu, Chen, Ping, Rantanen, Ville, Holte, Harald, Delabie, Jan, Karjalainen-Lindsberg, Marja-Liisa, Björkholm, Magnus, Fluge, Øystein, Pedersen, Lars Møller, Fjordén, Karin, Jerkeman, Mats, Eriksson, Mikael, Hautaniemi, Sampsa, Leppä, Sirpa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953211/ https://www.ncbi.nlm.nih.gov/pubmed/24625556 http://dx.doi.org/10.1371/journal.pone.0091031 |
Ejemplares similares
-
Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
por: Leivonen, S-K, et al.
Publicado: (2017) -
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study
por: Pauly, F, et al.
Publicado: (2016) -
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2017) -
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
por: Autio, Matias, et al.
Publicado: (2020) -
Language-Agnostic Reproducible Data Analysis Using Literate Programming
por: Vassilev, Boris, et al.
Publicado: (2016)